George Tidmarsh, director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research (CDER), has resigned amid serious concerns about his personal conduct, a spokesperson for the Department of Health and Human Services said. Tidmarsh was placed on administrative leave following the Office of the General Counsel and Office of the Inspector General were alerted to the concerns, the spokesperson told Reuters. Appointed in July, Tidmarsh oversaw one of the FDA’s largest divisions, which regulates both prescription and over-the-counter medications. "Secretary Kennedy expects the highest ethical standards from all individuals serving under his leadership and remains committed to full transparency," the HHS said.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!